明德生物：拟共同投资设立私募基金 投向光互联、半导体等人工智能基础设施/终端产业链

Group 1 - The core point of the article is that Mingde Bio (002932) has signed a partnership agreement to invest in a venture capital fund focused on unlisted companies in the AI infrastructure and terminal industry [1] - The total scale of the fund is 950 million yuan, with the company contributing 300 million yuan, representing a 31.5789% stake [1] - The investment areas primarily include equity in unlisted enterprises, particularly in sectors such as optical interconnection and semiconductors [1]